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Abstract
Increased fracture risk is commonly reported in cancer patients receiving radiotherapy, particularly 
at sites within the field of treatment. The direct and systemic effects of ionizing radiation on bone 
at a therapeutic dose are not well characterized in clinically relevant animal models. Using twenty-
week male C57Bl/6 mice, effects of irradiation (right hindlimb; 2 Gy) on bone volume and 
microarchitecture were evaluated prospectively by microcomputed tomography and 
histomorphometry and compared to contralateral-shielded bone (left hindlimb) and non-irradiated 
control bone. One-week post-irradiation, trabecular bone volume declined in irradiated tibiae 
(−22%; p<0.0001) and femora (−14%; p=0.0586) and microarchitectural parameters were 
compromised. Trabecular bone volume declined in contralateral tibiae (−17%; p=0.003), and no 
loss was detected at the femur. Osteoclast number, apoptotic osteocyte number and marrow 
adiposity were increased in irradiated bone relative to contralateral and non-irradiated bone, while 
osteoblast number was unchanged. Despite no change in osteoblast number one-week post-
irradiation, dynamic bone formation indices revealed a reduction in mineralized bone surface and 
a concomitant increase in unmineralized osteoid surface area in irradiated bone relative to 
contralateral and non-irradiated control bone. Further, dose- and time-dependent calvarial culture 
and in vitro assays confirmed that calvarial osteoblasts and osteoblast-like MC3T3 cells were 
relatively radioresistant, while calvarial osteocyte and osteocyte-like MLO-Y4 cell apoptosis was 
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induced as early as 48h post-irradiation (4 Gy). In osteoclastogenesis assays, radiation exposure (8 
Gy) stimulated murine macrophage RAW264.7 cell differentiation and co-culture of irradiated 
RAW264.7 cells with MLO-Y4 or murine bone marrow cells enhanced this effect. These studies 
highlight the multi-faceted nature of radiation-induced bone loss by demonstrating direct and 
systemic effects on bone and its many cell types using clinically relevant doses and have important 
implications for bone health in patients treated with radiation therapy.
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Introduction
Irradiation at sites of malignancy in adjunct with surgery and/or chemotherapy has proven to 
be an effective anti-cancer strategy that reduces mortality rates.[1] As disease-free survival 
continues to improve with effective treatment approaches, long-term side effects of 
radiotherapy on the skeletal system have emerged. A typical treatment regimen of ionizing 
radiation for gynecological cancers consists of administration of up to 60 Gy fractionated 
over a six-week span.[2,3] Healthy by-standing tissue, including bone, is estimated to absorb 
up to half of this dose (~30 Gy).[3,4] Despite efforts to minimize dose-limiting side effects 
by protecting healthy tissues, the incidence of pathological fracture at sites in the direct path 
of therapeutic irradiation is reportedly increased relative to non-irradiated skeletal sites in 
cancer patients and survivors.[5–11] Patients receiving radiotherapy for pelvic tumors 
including cervical, rectal and anal cancers have increased risk of hip fracture relative to 
cancer patients who undergo surgery or chemotherapy alone.[6–11] Likewise, a dose-
dependent relationship between radiation and rib fracture incidence has been identified in 
breast cancer patients.[5] In addition to evidence for direct effects of radiation therapy on 
bone, systemic reduction in bone density has been detected in cancer patients within the first 
year of radiotherapy,[7,12,13] and radiation-treated breast cancer patients are reported to have 
hip fracture rates up to 20 times higher than average reported fracture rates for breast cancer 
patients four years after diagnosis.[14–16] Taken together, these striking clinical findings 
implicate that both direct and systemic mechanisms are at play in the pathology of radiation-
induced bone loss.
While the deleterious effects of ionizing radiation on bone are widely accepted,[3,17] the 
direct and systemic mechanism(s) of radiation-induced bone loss at the cellular level are not 
well characterized, particularly in models which mimic a clinical setting of radiotherapy 
where exposure occurs at a localized site. Effects of radiation on bone typically have been 
characterized using total-body irradiation models where widespread systemic inflammation 
and radiation-induced hypogonadism can complicate data interpretation with regard to bone. 
Here we present results using a murine model of radiotherapy wherein the right hindlimb 
was selectively irradiated at a relatively low, clinically relevant dose of 2 Gy. Direct and 
indirect radiation-induced changes in bone volume and microarchitectural structures of bone 
were monitored prospectively for one week at irradiated bone sites and contralateral-
shielded bone sites, and compared to sham-irradiated age-matched non-irradiated controls. 
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The skeletal response to irradiation is further characterized at the cellular level in vivo 
through quantitative histomorphometric analysis and in vitro.
Materials and Methods
Animals
The animal protocols utilized for these studies were approved by the Institutional Animal 
Care and Use Committee at Indiana University in accordance with the National Institutes of 
Health Guide for the Care and Use of Laboratory Animals. Twenty-week male C57Bl/6 
mice were purchased from Harlan Laboratories (Indianapolis, IN) and housed in plastic 
cages with access to water and mouse chow ad libitum and maintained on a 12h light/dark 
schedule at 22±2°C. After one week of acclimation, mice were anesthetized with a 
ketamine/xylazine cocktail and underwent irradiation at a dose of 2 Gy (1.6 Gy/min for 
1.25min; 320kV Precision X-ray machine) of a 2cm by 2cm area covering the right 
hindlimb, which included the femur, tibia and foot, while the contralateral limbs, torso 
(including reproductive organs) and head were covered with a malleable lead shield. Control 
mice were similarly manipulated, anesthetized, and underwent sham irradiation (0 Gy).
Bone micro-computed tomography (μCT) imaging
Bone μCT was performed at the proximal metaphysis of the tibia and the distal metaphysis 
and mid-diaphysis of the femur using a high-resolution imaging system (μCT40; Scanco 
Medical AG) on isoflurane-anesthetized mice. MicroCT scans were acquired using a 10μm3 
isotropic voxel size, 55kVp peak X-ray tube potential, 200ms integration time, and were 
subjected to Gaussian filtration. Trabecular bone microarchitecture was evaluated in the 
proximal metaphysis of the tibia in a region that began 0.4mm distal to the growth plate and 
extended distally 1.0mm, and at the femoral distal metaphysis in a region that began 0.5mm 
proximal to the growth plate and extended proximally 1.0mm. A threshold of 170mg 
HA/cm3 was used to segment bone from surrounding soft tissue. Trabecular bone outcomes 
included trabecular bone volume fraction (BV/TV; %), trabecular thickness (Tb.th; mm), 
trabecular number (Tb.N; mm−1), trabecular separation (Tb.Sp; mm), and connectivity 
density (Conn.D; mm−3). We chose to examine both the distal femur and proximal tibia 
bone sites in order to gain a more complete picture of the effects of single-site irradiation on 
bone. Scan acquisition and analyses were conducted in accordance with guidelines for use of 
μCT in rodents.[18]
Dual-energy X-ray absorptiometry (DXA) imaging
In vivo measurement of fat mass, lean mass and bone mineral density (BMD) was performed 
on anesthetized mice (ketamine/xylazine) using a PIXImus II densitometer (GE Lunar, 
Madison, WI) calibrated with a phantom of defined density. Total body composition and 
BMD of the proximal tibia and distal femur were analyzed at baseline one day prior to 
irradiation and at the termination of the study one week post-irradiation in order to assess a 
percent change over time.
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Bone histology and histomorphometry
Hindlimbs were removed from mice at the time of experimental termination, fixed in 10% 
neutral-buffered formalin for 48h and stored in 70% ethanol. Tibiae were decalcified in 10% 
EDTA for two weeks, processed using an automated tissue processor (Excelsior, 
Thermoelectric), and embedded in paraffin. Mid-sagittal 3.5μm sections were stained with 
hematoxylin and eosin (H&E) with orange G and phloxine to visualize new bone, and with 
TRAP stain (tartrate-resistant acid phosphatase) to visualize osteoclasts. The number of 
osteoclasts (N.Oc/BS) and osteoblasts (N.Ob/BS) were identified and quantitated relative to 
the bone surface, and the total number of adipocytes distal to the growth plate in the 
proximal tibial metaphysis were quantified and expressed as adipocytes/mm2. Paraffin 
embedded sections were evaluated for apoptotic nuclei by detection of terminal 
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), as per manufacturer’s 
protocol (Klenow FragEL™ Fragmentation Detection Kit; Calbiochem).
In order to assess dynamic bone parameters, undecalcified femora were dehydrated in 
graded alcohol (70–100%), cleared in xylene, and infiltrated and embedded with methyl 
methacrylate (MMA) under vacuum. Using an automated microtome (Microm HM 360, 
Thermo Scientific), 45μm transverse sections were removed from the femoral diaphysis at 
the midsection and mounted unstained on standard microscope slides. Bones were double-
labeled with calcein at the day of irradiation and at day six prior to the scheduled terminal 
necropsy at day seven to measure the following dynamic parameters: bone formation rate/
bone surface (BFR/BS; μm3/μm2/day), mineral apposition rate (MAR; μm/day) and 
mineralizing surface (MS/BS; %). In order to differentiate mineralized and osteoid bone 
tissue, sections were deplasticized, rehydrated, stained with von Kossa and counterstained 
with tetrachrome (MacNeal; Polysciences) for improved contrast. Non-mineralized osteoid 
bone tissue was assessed by measurement of the following parameters: osteoid volume (OV/
BS), osteoid surface (OS/BS) and osteoid width (μm). All sections were viewed on a Leica 
DM LB compound microscope outfitted with a Q-Imaging Micropublisher Cooled CCD 
color digital camera (Nuhsbaum Inc, McHenry, IL). Images were captured and analyzed 
using BioQuant Image Analysis Software version 12.1 (BIOQUANT Image Analysis 
Cooperation, Nashville, TN).
Calvarial bone culture assays
Calvariae were excised under sterile conditions from four-day-old Swiss White mice, cut in 
mid-sagitally, and incubated in 1mL of BGJ medium (Sigma) with 1% BSA, as previously 
described.[19] Calvarial bone cultures were irradiated on the same day of excision (0.244 Gy/
min; Faxitron X-ray; n=4/group) or treated with insulin as a positive control for bone 
formation (100μg/mL) and cultured up to ten days with media refreshment occurring every 
72h. Bones were fixed, decalcified, paraffin-embedded, and sectioned. The total number of 
osteoblasts and new bone area (%) were quantified in blinded fashion on H&E stained 
sections, as previously described,[19] and apoptotic (TUNEL+) osteoblasts and osteocytes 
were quantitated and expressed as a percentage of the total for each respective cell type.
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Flow cytometry
Murine calvarium-derived preosteoblastic MC3T3 cells (ATCC) and murine long bone-
derived osteocyte-like MLO-Y4 cells[20] were cultured in alpha-MEM with L-glutamin 
supplemented with antibiotics. Cells were seeded in 12-well plates (100,000 cells/well), 
grown to 80% confluence over a 48h period and irradiated with 2–20 Gy using 160kVp X-
ray at a dose rate of 2.44 Gy/min (Faxitron Bioptics, LLC Tucson, AZ) or treated with 
dexamethasone (Sigma) as a positive control for apoptosis. Washed and trypsinized cells 
were resuspended in 500μL of binding buffer containing 5μL of Annexin V-EGFP and 5μL 
of propidium iodide (PI; Biovision). Tubes were incubated at room temperature for 5m in 
the dark. Annexin-V-EGFP binding and PI staining were assessed by flow cytometry using a 
FACSCalibur flow cytometer (BD Biosciences) and data were analyzed using Cell Quest 
software (BD Biosciences). The percentage of apoptotic cells was based on the evaluation of 
10,000 events for each culture condition.
Osteoclastogenesis assays
Murine macrophage RAW264.7 cells (ATCC) were maintained in alpha-DMEM medium 
supplemented with antibiotics and 10% fetal bovine serum. Cells were seeded in 24-well 
plates (25,000/well) on a bone-mimetic surface (Corning OsteoSurface) in medium 
supplemented with deoxyribonucleosides, ribonucleosides, L-glutamine and RANKL (5–
50ng/mL; R&D Systems) to stimulate osteoclastogenesis. In a parallel study, osteocyte-like 
MLO-Y4 or flushed bone marrow (BM) cells (125,000/well) were co-cultured with 
RAW264.7 cells under identical conditions. Briefly, BM cells were isolated under sterile 
conditions from the long bones of male C57Bl/6 mice and cultured on 90mm petri dishes for 
2.5h at 37°C in alpha-DMEM and non-adherent BM cells were quantified and used for co-
culture studies. Wells were irradiated with 160kVp X-rays at a dose rate of 2.44 Gy/min 
using 2 Gy fractions applied consecutively on days one to four over the course of one week, 
cumulating doses of 2–8 Gy for each treatment condition. Medium was refreshed on day 4 
and cells were fixed on day seven and stained for TRAP activity. Osteoclasts, defined as 
TRAP+ multinucleated (≥3) cells, were quantified for each condition (n=4 wells/group). 
Cells were cleared from the plate surface with 10% bleach, washed, dried and resorption pits 
were visualized on a Leica DM LB compound microscope outfitted with a Q-Imaging 
Micropublisher Cooled CCD color digital camera (Vashaw Scientific Inc.). Images were 
captured and analyzed using MetaMorph software (Universal Imaging Corporation).
Statistical analyses
Differences were determined by one-way ANOVA, with Bonferroni post hoc testing, or by 
paired or unpaired student t test, as appropriate (GraphPad, Prism 6, version 6.0c). Results 
are expressed as mean ± SEM and p<0.05 was considered significant.
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Results
Skeletal and body composition changes following localized irradiation of the right 
hindlimb
Local and systemic effects of single site exposure to ionizing radiation were assessed by 
measurement of trabecular bone volume and microarchitecture at the proximal tibia and 
distal femur. Use of μCT allowed us to delineate a purely trabecular region of interest such 
that changes in bone volume and microarchitectural structure in highly metabolically active 
trabecular compartments could be detected with precision.[18] Irradiated hindlimbs and 
contralateral lead-shielded hindlimbs were compared to hindlimbs from age-matched non-
irradiated control mice. Seven days post-irradiation (2 Gy), trabecular bone volume 
(BV/TV; %), was reduced by 22% at the tibia and by 14% at the femur relative to baseline 
measurements in irradiated limbs (Fig. 1A–C; Table 1). These changes in irradiated bone 
were significant relative to changes observed in non-irradiated control tibiae and femora 
(p<0.0001 and p<0.05, respectively) (Fig. 1A–C). Bone volume of contralateral tibiae in 
irradiated mice was reduced by 17% relative to baseline measurements seven days post-
irradiation (Fig. 1A,C; Table 1), and this decline was significant relative to changes in non-
irradiated control bone volume at the tibia (p<0.001) (Fig. 1A,C). Further, bone 
microarchitecture was altered in irradiated bone, evidenced by a 50% reduction in 
connectivity density, a 16% reduction in trabecular number and a 20% increase in trabecular 
spacing relative to baseline measurements at the proximal tibia (Fig. 1D–F; Table 1). This 
loss of connectivity density was significant (p<0.05) relative to changes observed in sham 
control tibiae (Fig. 1D). At the femur, connectivity density and trabecular number were 
reduced by 45% and 13%, respectively, and spacing was increased by 16% relative to 
baseline measurements (Fig 1D–F; Table 1), with changes in trabecular number significantly 
reduced (p<0.01) relative to changes observed in sham control femora (Fig. 1E). Similar 
trends were detected at the microarchitectural level at contralateral bone sites (Fig 1D–G; 
Table 1); however, statistical significance was reached relative to changes observed in sham 
controls only in the case of reduced trabecular thickness (p<0.05) (Fig. 1G). Cortical bone 
properties at the femoral midshaft assessed by μCT were not different between groups (data 
not shown).
One week after irradiation of the right hindlimb, body weight declined significantly 
(p<0.001) relative to non-irradiated sham control mice (Fig. 2A). No change was observed 
in lean mass percentage between groups (Fig. 2B), as assessed by DXA, however, body fat 
mass declined significantly in irradiated animals one week after exposure (−22%; p<0.0001) 
(Fig. 2C), and this change could explain the observed decline in body weight. Changes in 
BMD by DXA, a 2-dimensional integration of bone that includes both trabecular and 
cortical bone compartments, were not detected at the proximal tibia or distal femur (Fig. 
2D).
Cellular responses in bone to single site irradiation in vivo
Direct and systemic effects of focal irradiation in vivo were studied at the cellular level in 
bone tissue collected from irradiated and control mice. Quantitative histomorphometric 
analysis of TRAP+ osteoclasts revealed a statistically significant increase (p<0.05) in 
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osteoclast number in irradiated bone relative to contralateral and control tibiae one week 
after irradiation (Fig. 3A,B). No difference in osteoblast number was noted (Fig. 3C). 
Detection of fragmented DNA (TUNEL+) in osteocytes, an early stage marker of cellular 
apoptosis,[21] was increased in the trabecular bone compartment of irradiated bone 
compared to non-irradiated controls (p<0.05) (Fig. 3D). Quantitation of empty lacunae in 
trabecular bone, a late indicator of osteocyte death, revealed no significant differences 
between irradiated and non-irradiated bones in either trabecular or cortical bone 
compartments (Fig. 3E).
Dynamic histomorphometric analyses were carried out in order to determine whether 
osteoblast activity was altered one week post-irradiation. Bone formation rate (BFR/BS; 
μm3/μm2/d) was reduced (p<0.05) in irradiated femora relative to controls (Fig. 4B), and the 
mineralized surface relative to total bone surface (MS/BS) was likewise reduced in 
irradiated bone relative to both control (p<0.01) and contralateral femora (p<0.05) (Fig. 4D). 
Osteoblast activity was also assessed by measurement of its cellular byproduct, osteoid, or 
unmineralized bone matrix. Interestingly, we found that osteoid volume (OV/BV) and 
osteoid surface (OS/BS) were increased (p<0.05) in irradiated femora (Fig. 4E,F) relative to 
controls, and that the mean osteoid width was thicker (p<0.05) in bone that had been 
irradiated, relative to contralateral bone (Fig. 4G).
In alignment with previous reports of increased marrow adiposity following radiation 
therapy,[22] the adipocyte content of the marrow cavity of irradiated long bones was 
dramatically increased one week following exposure to 2 Gy (p<0.001) (Fig. 5A,B), and this 
effect was restricted to irradiated bones, with no differences detected in contralateral limbs 
relative to sham-control bone (Fig. 5A,B).
Differential response to irradiation by bone cells ex vivo
Next, we characterized the time- and dose-dependent effects of radiation on bone in vitro 
using a mouse calvarial bone formation assay. Consistent with results obtained from our in 
vivo studies, calvarial osteoblast number was not altered at any time point (1–10d) when 
irradiated at a dose of 2 Gy (Fig. 6A). Recapitulating our findings in vivo, though at a 
slightly later time point (10d vs. 7d), irradiation of bone at 2 Gy induced a significant 
increase in new bone (p<0.01) in irradiated calvarial tissue relative to non-irradiated control 
tissues (Fig. 6B). Exposure of bone to the higher dose of 10 Gy led to an eventual reduction 
in osteoblast number (p<0.001) relative to control tissues at the 10d time point, with no 
change in new bone formation at any time point (Fig. 6AB). Detection of TUNEL+ 
apoptotic osteoblasts in the same calvarial assay was negligible for all groups (Fig. 6C), 
however, similar to what was observed in vivo, osteocyte apoptosis was induced both dose- 
and time-dependently in vitro (Fig. 6D,E).
To further expand our understanding of the relative radiosensitivity of osteoblasts and 
osteocytes, we quantitated expression of Annexin V, a late stage marker of cellular 
apoptosis[23] using osteoblast-like MC3T3 cells and osteocyte-like MLO-Y4 cells. MC3T3 
cell expression of Annexin V was significantly elevated at a dose of 10 Gy or higher 24h 
and 48h after radiation exposure (p<0.05 and p<0.001, respectively) (Fig. 7A,B). Very 
similar results were observed in MLO-Y4 cell populations (Fig. 7C), however, the dose-
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response study at 48h post-irradiation revealed elevated expression of Annexin V (p<0.05) 
in osteocyte-like cells after as little as 4 Gy, and expression of Annexin V increased 
concomitantly with increasing doses of radiation up to 20 Gy (Fig. 7D,E).
Finally, effects of irradiation on osteoclastogenesis were evaluated using the murine 
macrophage osteoclast precursor cell line RAW264.7. Under minimal stimulation with the 
osteoclastogenic peptide RANKL (5ng/mL), direct irradiation of osteoclast precursor cells 
lead to a significant increase (p<0.01) in osteoclast number (Fig. 8A) and activity (Fig. 8B), 
as assessed by measurement of resorption pit area on a bone-mimetic surface, relative to 
non-irradiated control wells. These effects, however, were observed only at a cumulative 
dose of 8 Gy. Interestingly, irradiation at 8 Gy of a co-cultured population of RAW264.7 
with osteocyte-like MLO-Y4 cells or with flushed murine bone marrow (BM) cells 
increased osteoclast differentiation by nearly six fold relative to the osteoclast numbers in 
wells with irradiated RAW264.7 cells alone (p<0.05) (Fig. 8A). Resorption area was 
increased in wells with an irradiated co-culture of RAW264.7 cells and BM cells relative to 
irradiated RAW264.7 cells alone (Fig. 8B), but no relative difference was observed in 
resorption pit area in irradiated wells of RAW264.7 cells combined with MLO-Y4 cells.
Discussion
Radiation-induced bone loss has historically been attributed to a long-term impairment of 
bone formation resulting from reduced osteoblast cell proliferation and the depletion of the 
adult stem cell population from which bone-forming osteoblast cells are derived.[7,13,24–26] 
Our results are in agreement with recent studies that challenge the view that radiation-
induced bone loss is primarily a late-stage event,[16,27–29] as we present evidence for loss in 
trabecular bone volume and microstructure as early as one week post-irradiation. 
Furthermore, bone loss was detected in our model at sites of irradiation as well as at sites 
outside of the field of radiation, demonstrating that both local and systemic effects of 
irradiation have deleterious effects on the skeleton.
A rapid increase in osteoclastogenesis has been previously reported three days after total-
body exposure.[28,29] Consistent with these reports, osteoclast number remained increased in 
trabecular bone one-week post-irradiation in our single-limb model. Interestingly, in vitro 
osteoclastogenesis assays presented here suggest that the direct effect of irradiation on 
osteoclast precursor cell differentiation is modest, but that irradiation of a co-culture of 
osteocyte-like cells or bone marrow cells with osteoclast precursors enhances 
osteoclastogenesis. These results indicate that signals from the osteocyte and/or bone 
marrow stroma may contribute to radiation-induced osteoclastic bone resorption. Using 
conditioned media collected from irradiated cells, we have yet to find evidence that soluble 
factors secreted from the osteocyte or bone marrow stroma are responsible for stimulation of 
osteoclastogenesis in this setting. Further studies will be required to identify possible signals 
within the bone microenvironment that contribute to osteoclast activation in the context of 
irradiation. The suppression of osteoclast activity using a bisphosphonate has previously 
been shown to abrogate radiation-induced bone loss in a preclinical model of total-body 
irradiation.[29] Collectively, preclinical data implicate a rapid and potentially sustained 
increase in osteoclastic bone resorption as one of the primary mechanisms of radiation-
Wright et al. Page 8
J Bone Miner Res. Author manuscript; available in PMC 2016 July 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
induced bone loss, supporting the use of adjuvant anti-resorptive therapy for cancer patients 
undergoing radiotherapy.
In addition to an upregulation of osteoclastic bone resorption in vivo, dynamic bone indices 
revealed a defect in the formation of mineralized bone at sites of direct irradiation, 
supporting the long-standing notion that ionizing radiation impairs bone 
formation.[7,13,24–26,29] The timing however of these adverse effects on bone mineralization 
may occur sooner than previously thought, and moreover, impaired mineralization in our 
model was not driven by ablation of the osteoblast. To this point, the number of osteoblasts 
was not altered by 2 Gy exposure in vivo, consistent with our calvarial bone culture assays, 
which demonstrated that the proliferation of osteoblast cells was impaired only at higher 
doses (10 Gy) with no evidence of induction of apoptosis. Our in vivo and in vitro results 
consistently demonstrated that osteoblasts are relatively resistant to radiation-induced 
apoptosis. This is in full agreement with previous reports, which similarly demonstrate that 
osteoblast cells remain viable following exposure to doses between 10–30 Gy.[30,31] Despite 
the impaired mineralization, a compensatory surge in osteoblast apposition of new osteoid 
was detected in our studies one-week post-irradiation, and this effect occurred 
concomitantly with the sustained increase in osteoclastogenesis, suggesting that radiation 
exposure at this dose did not compromise the coupling of resorption and formation mediated 
by bone’s basic multicellular unit.
Little is known about the role of the osteocyte in radiation-induced bone loss, and the few 
studies that do account for osteocyte-related outcomes report mixed results.[3,7,25,32] In our 
in vivo and in vitro models, doses of radiation as low as 2–4 Gy induced osteocyte apoptosis, 
providing evidence that the osteocyte may be highly sensitive to radiation exposure. 
Moreover, osteocytes appeared more radiosensitive than osteoblasts when compared head-
to-head in proliferation and apoptosis assays. Impaired osteocyte function and/or cell death 
following radiation exposure could blunt the mechanosensitivity of bone and its response to 
dynamic loads, slowing bone growth and retarding bone repair, thus compromising its 
material strength. Radiation-induced osteocyte apoptosis may be a previously unappreciated 
contributor to the etiology of long-term bone loss and increased risk of fracture in cancer 
patients.
A reciprocal relationship has been identified clinically between marrow adiposity and bone 
volume in cancer patients treated with radiotherapy.[6,7,33] Consistent with these clinical 
findings, we report a near threefold increase in marrow adiposity in conjunction with >20% 
reduction in bone volume in irradiated tibiae. Radiation-induced DNA damage to bone 
marrow mesenchymal stem cells (MSCs) from which bone-forming osteoblasts are derived 
has been linked to cellular senescence resulting in reduced osteogenic potential and 
increased adipogenic potential of MSCs.[22,30,33–38] Despite no observed change in 
osteoblast number after one week, exhaustion of the MSC pool via an adipogenic lineage 
commitment switch could lead to a decrease in osteoblast number in our model at later time 
points, a postulate to be examined in future studies. While the underlying mechanisms 
responsible for fatty infiltration of the marrow following radiation exposure are still being 
clarified, it is clear that this marrow defect is strongly associated with bone loss and 
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increased fracture risk,[6,7,33] and that damage to MSCs following radiotherapy could drive 
this defect in human cancer patients.
Many groups have reported weight loss in mice following total-body irradiation due to 
systemic toxicity and bone marrow suppression.[39–41] The mechanism of body weight 
decline and loss in fat mass following focal hindlimb irradiation, as observed in our study, is 
not known. Significant reduction in body weight in men [42] and women[43] has been 
associated with reduced bone mineral density (BMD) and increased fracture risk over time 
in clinical trials. Systemic changes in body weight and body composition in our mice could 
be a contributing factor to bone loss bilaterally at both contralateral and irradiated bone sites.
The single-limb irradiation model utilized here is advantageous in that direct and systemic 
effects of radiation on bone can be delineated. In agreement with clinical reports of systemic 
osteopenia in radiation-treated cancer patients,[7,12,13] significant bone loss was detected at 
sites outside the field of irradiation in our mice. These results lend credence to the clinical-
applicability of our model. Vascular damage, inflammation and the generation of reactive 
oxygen species (ROS) are thought to contribute to deleterious effects of radiation at distant 
skeletal and non-skeletal sites.[16,44] Histomorphometric differences at contralateral bone 
sites relative to control bone sites did not reach significance at one-week post-irradiation. 
Cellular changes in bone in the contralateral limbs (e.g., increased osteoclast numbers) likely 
occurred at an earlier time point following irradiation (<7 days post-irradiation), and thus, 
our data at the one-week time point did not capture these relatively acute changes at 
contralateral sites. Pro-resorptive inflammatory cytokines including interleukin (IL)-1, IL-6, 
IL-17 and tumor necrosis factor (TNF)-α are known to be highly elevated within 24–48hrs 
following radiation exposure,[44] likely driving early bone loss following irradiation.[28,29] 
Serum levels of IL-1, IL-6, IL-17 and TNF-α were assayed in our irradiated mice one-week 
post-irradiation, however, no differences were detected at this time point relative to control 
mice (data not shown), indicating that the period of increased inflammatory tone had likely 
subsided. Nevertheless, our finding of systemic bone loss following hindlimb radiation 
demonstrates that radiation-induced skeletal complications cannot be solely attributed to 
direct effects on bone, and the identification of the molecular mediator(s) of systemic bone 
loss could be important in developing bone-protective therapeutics for cancer patients.
While the prevention of pathological fractures in cancer patients is critical, other skeletal 
complications of radiation-induced bone loss may be important to consider. Multiple 
preclinical models have demonstrated that a heightened state of osteoclastic bone resorption 
can fuel the progression of cancer growth in bone.[45–47] Radiation-induced bone loss 
therefore could have serious implications with regard to cancer recurrence and skeletal 
metastasis in patients. During a state of heightened resorption, the bone microenvironment is 
rendered particularly favorable for cancer cell survival through the release of immobilized 
growth factors stored in the bone matrix (e.g., transforming growth factor-β, insulin-like 
growth factors, fibroblast growth factors, platelet-derived growth factor).[48–49] 
Additionally, osteoclast-derived proteolytic enzymes such as cathepsin-K and matrix 
metalloproteinase-9 have been shown to promote angiogenesis, cancer cell invasiveness and 
engraftment at metastatic sites.[47,49] Thus, it is critically important to monitor the skeletal 
health of cancer patients undergoing radiation treatment, or any anti-cancer therapeutic 
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known to adversely affect bone (e.g., glucocorticoids, anti-estrogen therapy, GnRH 
agonists), as treatment-induced bone loss could increase the likelihood of cancer recurrence 
in bone.[50] Adjuvant treatment with an anti-resorptive therapy may be considered in an 
effort to prevent treatment-induced skeletal complications. Preclinical studies will be 
necessary to determine whether radiation-induced bone loss (direct or systemic) can 
influence the progression of cancer bone metastases.
In summary, the etiology of radiation-induced skeletal complications appears multifactorial. 
In our therapeutic model of single-limb irradiation, osteoclast activation, osteocyte apoptosis 
and increased marrow adiposity, which is associated with MSC senescence, appear to 
contribute to bone loss at sites of direct irradiation. Similar to what is reported clinically, 
systemic bone loss was detected in our model at distant sites, indicating that local 
perturbations to the bone microenvironment can have wide-sweeping systemic effects. The 
identification of mediators and mechanisms of both direct and systemic radiation-induced 
bone loss could be important for the development of therapies that prevent skeletally related 
events in cancer patients and survivors. Further studies will be necessary to assess the full 
time course of changes in bone at the microarchitectural and cellular levels, at both 
irradiated and non-irradiated bone sites. Taken together, these studies expand our current 
understanding of the radiosensitivity of bone tissue to the insult of ionizing radiation and 
emphasize the multi-dimensional and often complex nature of bone loss.
Acknowledgments
Grant support: This work was supported by the Department of Defense Prostate Cancer Research Program 
postdoctoral training award PC101890 (LEW, JTB, HSK), the National Heart, Lung, and Blood Institute (NHLB/
NIH) T35 HL110854 (LEC, AMS), the Jerry and Peggy Throgmartin Endowment (TAG), the Indiana Economic 
Development Fund, the National Cancer Institute (NCI/NIH) R01-CA69158 & U01-CA143057 (TAG), the V-
Foundation (TAG), The Susan G. Komen Foundation (TAG), the National Institute of Arthritis and 
Musculoskeletal and Skin Diseases (NIAMS/NIH) R01-AR059221 (TAG) and a generous donation from the 
Withycombe Family (TAG).
References
1. Bernier J, Hall EJ, Giaccia A. Radiation oncology: a century of achievements. Nat Rev Cancer. 
2004; 4:737–47. [PubMed: 15343280] 
2. Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum 
Reprod Update. 2001; 7(6):535–43. [PubMed: 11727861] 
3. Willey JS, Lloyd SAJ, Nelson GA, Bateman TA. Ionizing radiation and bone loss: space exploration 
and clinical therapy applications. Clin Rev Bone Miner Metab. 2011; 9(1):54–62. [PubMed: 
22826690] 
4. Sparks RB, Crowe EA, Wong FC, Toohey RE, Siegel JA. Radiation dose distribution in normal 
tissue adjacent to tumors containing 131I or 90Y: the potential for toxicity. J Nuclear Med. 2002; 
43(8):1110–4.
5. Pierce SM, Recht A, Lingos TI, Abner A, Vicini F, Silver B, Herzog A, Harris JR. Long-term 
radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients 
with early stage breast cancer. Int J Radiat Oncol Biol Phys. 1992; 23:912–923.
6. Baxter NN, Habermann EB, Tepper JE, Durham SB, Virnig BA. Risk of pelvic fractures in older 
women following pelvic irradiation. JAMA. 2005; 294(20):2587–93. [PubMed: 16304072] 
7. Mitchell JM, Logan PH. Radiation-induced changes in bone. Radiographics. 1998; 18(5):1125–36. 
[PubMed: 9747611] 
Wright et al. Page 11
J Bone Miner Res. Author manuscript; available in PMC 2016 July 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
8. Williams HJ, Davies AM. The effect of X-rays on bone: a pictorial review. Eur Radiol. 2006; 16(3):
619–33. [PubMed: 16237551] 
9. Kwon JW, Huh SJ, Yoon YC, Choi SH, Jung JY, Oh D, et al. Pelvic bone complications after 
radiation therapy of uterine cervical cancer: evaluation with MRI. AJR Am J Roentgenol. 2008; 
191:987–94. [PubMed: 18806132] 
10. Igdem S, Alco G, Ercan T, Barlan M, Ganiyusufoglu K, Unalan B, et al. Insufficiency fractures 
after pelvic radiotherapy in patients with prostate cancer. Int J Radiat Oncol Bio Phys. 2010; 
77:818–23. [PubMed: 19879066] 
11. Ikushima H, Osaki K, Furutani S, Yamashita K, Kishida Y, Kudoh T, et al. Pelvic bone 
complications following radiation therapy of gynecological malignancies: clinical evaluation of 
radiation-induced pelvic insufficiency fractures. Gynecol Oncol. 2006; 103:1100–4. [PubMed: 
16919711] 
12. Nishiyama K, Inaba F, Higashihara T, Kitatani K, Kozuka T. Radiation osteoporosis—an 
assessment using single energy quantitative computed tomography. Eur Radiol. 1992; 2(4):322–5.
13. Hopewell JW. Radiation-therapy effects on bone density. Med Pediatr Oncol. 2003; 41(3):208–11. 
[PubMed: 12868120] 
14. Kirstensen B, Ejlertsen B, Mouridsen HT, Andersen KW, Lauritzen JB. Femoral fractures in 
postmenopausal breast cancer patients treated with adjuvant tamoxifen. Breast Cancer Res Treat. 
1996; 39:321–6. [PubMed: 8877012] 
15. Chen A, Maraicic M, Aragaki AK, Mouton C, Arendell L, Lopez AM, et al. Fracture risk increases 
after diagnosis of breast or other cancers in postemenopausal women: results from the Women’s 
Health Initiative. Osteoporos Int. 2009; 20:527–36. [PubMed: 18766294] 
16. Jia D, Gaddy D, Suva LJ, Corry PM. Rapid loss of bone mass and strength in mice after abdominal 
irradiation. Radiat Res. 2011; 176(5):624–35. [PubMed: 21859327] 
17. Suva LJ, Griffin RJ. The irradiation of bone: old idea, new insight. J Bone Miner Res. 2012; 27(4):
747–8. [PubMed: 22434644] 
18. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R. Guidelines for 
assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner 
Res. 2010; 25(7):1468–86. [PubMed: 20533309] 
19. Mohammad KS, Chirgwin JM, Guise TA. Assesssing new bone formation in neonatal calvarial 
organ cultures. Methods Mol Biol. 2008; 455:37–50. [PubMed: 18463809] 
20. Kato Y, Windle JJ, Koop BA, Mundy GR, Bonewald LF. Establishment of an osteocyte-like cell 
line, MLO-Y4. J Bone Miner Res. 1997; 12(12):2014–23. [PubMed: 9421234] 
21. Fawthrop DJ, Boobis AR, Davies DS. Mechanisms of cell death. Arch Toxicol. 1991; 65:437–44. 
[PubMed: 1929863] 
22. Georgiou KR, Hui SK, Xian CJ. Regulatory pathways associated with bone loss and bone marrow 
adiposity by aging, chemotherapy, glucocorticoid therapy and radiotherapy. Am J Stem Cell. 
2012; 1(3):205–24.
23. Vermes I, Haanen C, Steffens-Nakken H, Reutelingersperger CP. A novel assay for apoptosis. 
Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using 
fluorescein labeled Annexin V. J Immunol Methods. 1995; 184:39–51. [PubMed: 7622868] 
24. Sams A. The effect of 2000 r of x-rays on the internal structure of the mouse tibia. Int J Radiat Biol 
Relat Stud Phys Chem Med. 1966; 11(1):51–68. [PubMed: 4957987] 
25. Ergun H, Howland WJ. Postradiation atrophy of mature bone. CRC Crit Rev Diagn Imagin. 1980; 
12(3):225–43.
26. Green DE, Adler BJ, Chan ME, Rubin CT. Devastation of adult stem cell pools by irradiation 
precedes collapse of trabecular bone quality and quantity. J Bone Miner Res. 2012; 27(4):749–59. 
[PubMed: 22190044] 
27. Kondo H, Searby ND, Mojarrab R, Phillips J, Alwood J, Yumoto K, Almeida EA, Limoli CL, 
Globus RK. Total-body irradiation of postpubertal mice with (137)Cs acutely compromises the 
microarchitecture of cancellous bone and increases osteoclasts. Radiat Res. 2009; 171(3):283–9. 
[PubMed: 19267555] 
Wright et al. Page 12
J Bone Miner Res. Author manuscript; available in PMC 2016 July 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
28. Willey JS, Lloyd SA, Robbins ME, Bourland JD, Smith-Sielicki H, Bowman LC, Norrdin RW, 
Bateman TA. Early increase in osteoclast number in mice after whole-body irradiation with 2 Gy 
X rays. Radiat Res. 2008; 170(3):388–92. [PubMed: 18763868] 
29. Willey JS, Livingston EW, Robbins ME, Bourlard JD, Tirado-Lee L, Smith-Sielicki H, Bateman 
TA. Risedronate prevents early radiation-induced osteoporosis in mice at multiple skeletal 
locations. Bone. 2010; 46(1):101–11. [PubMed: 19747571] 
30. Despars G, Caronneau CL, Bardeau P, Coutu DL, Beausejour CM. Loss of the osteogenic 
differentiation potential during senescence is limited to bone progenitor cell and is dependent on 
p53. PLOS ONE. 2013; 8(8):1–11.
31. Szymczyk KH, Shapiro IM, Adams CS. Ionizing radiation sensitizes bone cells to apoptosis. Bone. 
2004; 34:148–56. [PubMed: 14751572] 
32. Rabelo GD, Beletti ME, Dechichi P. Histological analysis of the alterations on cortical bone 
channels network after radiotherapy: a rabbit study. Microsc Res Tech. 2010; 73(11):1015–8. 
[PubMed: 20169617] 
33. Hui SK, Khalil A, Zhang Y, Coghill K, Le C, Dusenbery K, Froelich J, Yee D, Downs L. 
Longitudinal assessment of bone loss from diagnostic computer tomography scans in gynecologic 
cancer patients treated with chemotherapy and radiation. Am J Obstet Gynecol. 2010; 203:353–57. 
[PubMed: 20684943] 
34. Cao X, Wu Z, Frassica D, Yu B, Pang L, Xian L, Wan M, Lei W, Armour M, Tryggestad E, Wong 
J, Wen CY, Lu WW, Frassica FJ. Irradiation induces bone injury by damaging bone marrow 
microenvironment for stem cells. Proc Natl Acad Sci USA. 2011; 108(4):1609–14. [PubMed: 
21220327] 
35. Carbonneau CL, Despars G, Rojas-Sutterlin S, Fortin A, Le O, et al. Ionizing radiation-induced 
expression of INK4a/ARF in murine bone marrow-derived stromal cell populations interferes with 
bone marrow homeostasis. Blood. 2012; 119:717–26. [PubMed: 22101896] 
36. Qui J, Zhu G, Chen X, Shao C, Gu S. Combined effects of gamma-irradiation and cadmium 
exposures on osteoblasts in vitro. Environ Toxicol Pharmacol. 2012; 33:149–57. [PubMed: 
22209727] 
37. Komori T. Regulation of bone development and maintenance by Runx2. Front Biosci. 2008; 
13:898–903. [PubMed: 17981598] 
38. Su W, Chen Y, Zeng W, Liu W, Sun H. Involvement of Wnt signaling in the injury of murine 
mesenchymal stem cells exposed to X-radiation. Int J Rad Biol. 2012; 88(9):635–41. [PubMed: 
22724383] 
39. Nunamaker EA, Artwohl JE, Anderson RJ, Fortman JD. Endpoint refinement for total body 
irradiation of C57Bl/6 mice. Comp Med. 2013; 63(1):22–8. [PubMed: 23561934] 
40. Duran-Struuck R, Dysko RC. Principles of bone marrow transplantation (BMT): providing optimal 
veterinary and husbandry care to irradiated mice in BMT studies. J Am Assoc Lab Anim Sci. 
2009; 48(1):11–22. [PubMed: 19245745] 
41. Xun CQ, Thompson JS, Jennings CD, Brown SA, Widmer MB. Effect of total body irradiation, 
busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release 
and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanded 
SCID mice. Blood. 1994; 83(8):2360–7. [PubMed: 8161803] 
42. Meyer HE, Sogaard AJ, Falch JA, Jorgensen L, Emaus N. Weight change over three decades and 
the risk of osteoporosis in men: The Norwegian Epidemiological Osteoporosis Studies 
(NOREPOS). Am J Epidemiol. 2008; 168(4):454–60. [PubMed: 18599490] 
43. Ensrud KE, Ewing SK, Stone KL, Cauley JA, Bowman PJ, Cummings SR. Intentional and 
unintentional weight loss increase bone loss and hip fracture risk in older women. J Am Geriatr 
Soc. 2003; 51(12):1740–7. [PubMed: 14687352] 
44. Lorimore SA, Coates PJ, Scobie GE, Miline G, Wright EG. Inflammation-type responses after 
exposure to ionizing radiation in vivo: a mechanism for radiation-induced bystander effects? 
Oncogene. 2001; 20(48):7085–95. [PubMed: 11704832] 
45. Ottewell PD, Wang N, Brown HK, Reeves KJ, Fowles CA, Croucher PI, et al. Zoledronic acid has 
differential anti-tumor activity in pre- and post-menopausal bone microenvironment in vivo. Clin 
Cancer Res. 2014; 20:1–11.
Wright et al. Page 13
J Bone Miner Res. Author manuscript; available in PMC 2016 July 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
46. Ottewell PD, Wang N, Meek J, Fowles AM, Croucher PI, Eaton CL, Holen I. Castration-induced 
bone loss triggers growth of disseminated prostate cancer cells in bone. Endocr Relat Cancer. 2014 
Oct; 21(5):769–81. Epub 2014 Jul 22. [PubMed: 25052474] 
47. Wright LE, Guise TA. The microenvironment matters: estrogen deficiency fuels cancer bone 
metastases. Clin Cancer Res. 2014; 20(11):2817–9. [PubMed: 24803577] 
48. Mohan S, Baylink DJ. Bone growth factors. Clin Orthop Relat Res. 1991; 263:30–48. [PubMed: 
1993386] 
49. Weilbaecher KN, Guise TA. Cancer to bone: a fatal attraction. Nature Rev Cancer. 2011; 11:411–
25. [PubMed: 21593787] 
50. Ratajczak MZ, Jadczyk T, Schneider G, Kakar SS, Kucia M. Induction of a tumor-metastasis-
receptive microenvironment as an unwanted and underestimated side effect of treatment by 
chemotherapy or radiotherapy. J Ovarian Res. 2013; 6:95. [PubMed: 24373588] 
Wright et al. Page 14
J Bone Miner Res. Author manuscript; available in PMC 2016 July 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 1. 
Effects of in vivo radiation exposure (2 Gy) to the right hindlimb on bone volume and 
trabecular microarchitecture in irradiated and non-irradiated (contralateral) bone of twenty-
week male C57Bl/6 mice one week post-irradiation relative to sham-irradiated control mice, 
as assessed by micro-computed tomography (μCT; SCANCO Viva40CT; 10μm voxel size, 
55kVp, 200ms integration time). Representative reconstructed images of μCT scans showing 
trabecular bone at the (A) proximal tibia and (B) distal femur were selected with a BV/TV 
% most representative of the group mean. Differences in (C) bone volume fraction (BV/TV), 
(D) connectivity density (Conn.D), (E) trabecular number (Tb.N), (F) trabecular spacing 
(Tb.Sp) and (G) trabecular thickness (Tb.Th) are presented as mean ±SEM of change 
relative to baseline with differences determined by one-way ANOVA with post-hoc testing 
(*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001; n=28 control, n=16 contralateral, n=16 
irradiated).
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Figure 2. 
Effects of in vivo radiation exposure (2 Gy) to the right hindlimb on (A) body weight, (B) 
total body lean mass, (C) total body fat mass and (D) bone mineral density (BMD) of the 
proximal tibia and distal femur in twenty-week male C57Bl/6 mice as assessed by dual 
energy X-ray absorptiometry (DXA). Data are expressed as mean percent change ±SEM 
relative to baseline measurements one week post-irradiation with differences determined by 
unpaired t test where ***p<0.001 and ****p<0.0001 (n=16/group).
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Figure 3. 
Effects of in vivo radiation exposure (2 Gy) to the right hindlimb on (A,B) osteoclasts, (C) 
osteoblasts, (C) apoptotic (TUNEL+) osteocytes and (D) empty lacunae in irradiated and 
non-irradiated (contralateral) bone relative to sham-irradiated control bone one week post-
irradiation. Results are presented as mean ±SEM with differences determined by one-way 
ANOVA with post-hoc testing where p<0.05.
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Figure 4. 
Effects of in vivo radiation exposure (2 Gy) to the right hindlimb on (B) bone formation rate 
(BFR/BS) (C) mineral apposition rate (MAR) (D) mineralized bone surface (MS/BS), (E) 
osteoid volume (OV/BV), (F) osteoid surface (OS/BS) and (G) osteoid width in irradiated 
and non-irradiated (contralateral) bone relative to sham-irradiated control bone one week 
post-irradiation. (A) Representative calcein-labeled bone sections are presented. (H) 
Representative von Kossa/MacNeal-stained sections show osteoblasts (black arrows) and 
osteoid bone (white arrows) relative to mineralized bone (black stain). Results are presented 
as mean ±SEM with differences determined by one-way ANOVA with post-hoc testing 
where *p<0.05 and **p<0.01.
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Figure 5. 
Effects of in vivo radiation exposure (2 Gy) to the right hindlimb on marrow adiposity in 
irradiated (right) and non-irradiated contralateral (left) bone relative to sham-irradiated 
control bone one week post-irradiation. (A) Results are presented as mean ±SEM with 
differences determined by one-way ANOVA with post-hoc testing (***p<0.001). (B) H&E 
sections of the left (contralateral) and right (irradiated) proximal tibiae of the same animal 
are presented.
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Figure 6. 
Effects of in vitro irradiation of mouse calvarial tissue on (A) osteoblasts, (B) new bone 
formation, (C) apoptotic (TUNEL+) osteoblasts and (D) apoptotic osteocytes. (E) 
Representative histological sections show TUNEL+ osteocytes (black arrows). Results are 
presented as mean ±SEM with differences determined by one-way ANOVA with post-hoc 
testing where *p<0.05, **p<0.01 and ***p<0.001 (n=4/group) relative to 0 Gy.
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Figure 7. 
Time and dose-dependent effects of irradiation on cellular apoptosis of (A,B) osteoblast-like 
MC3T3 cells and (C–E) osteocyte-like MLO-Y4 cells in vitro, as assessed by flow 
cytometry. Results are presented as mean ±SEM with differences determined by one-way 
ANOVA with post-hoc testing where *p<0.05 and ***p<0.001 relative to 0 Gy.
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Figure 8. 
Cumulative dose-dependent effects of radiation on (A) osteoclastogenesis and (B) resorption 
activity of RAW264.7 cells alone or in co-culture with MLO-Y4 cells or bone marrow (BM) 
cells. Results are presented as mean ±SEM with differences determined by one-way 
ANOVA with post-hoc testing where *p<0.05, **p<0.01 and ***p<0.001. Means without a 
common letter differ significantly as determined by one-way ANOVA of all treatment 
conditions with post-hoc testing where p<0.05.
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